PANS/PANDAS IVIG STUDY

PANS/PANDAS

IVIG Study

Given the recent changes, posted on ClinicalTrials.Gov, we wanted to update interested parties on the status of the PANS IVIG Trial. More specifically:
 
  • The trial has concluded the enrollment phase and has registered a total of 70 participants
  • Patients currently enrolled into the study will continue the study visits as per protocol
  • It will take a number of months to complete the treatment protocol for the enrolled participants
  • Data gathering and review are also expected to take a few additional months
Octapharma and PACE would like to thank you again for your support of the PANS IVIG trial.
 
Updated 6/26/2024
Untitled design
A9pg9kjv_e5f9ym_7lw

Take Action

Battling CPAE takes a dedicated team of amazing individuals all coming together for the greater good. We are grateful for any donation you are able to make.  Every dollar counts and all donations are 100% Tax Deductible.

Donate Now